This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt thereof) that degrades Proto-oncogene VAV 1 protein (VAV1). The chemical entities are useful, e.g., for treating a subject (e.g., a human subject) having an inflammatory or autoimmune disorder.
Environmentally benign nucleophilic substitution reaction of arylalkyl halides in water using CTAB as the inverse phase transfer catalyst
作者:Atul K. Godha、Jayaraman Thiruvengadam、Viswanadhan Abhilash、Prajwal Balgi、A. V. Narayanareddy、Kumaresan Vignesh、Amol V. Gadakh、A. M. Sathiyanarayanan、Sambasivam Ganesh
DOI:10.1039/c9nj03941d
日期:——
An environmentally benign, practically scalable and highly selective C-arylalkylation of active methylene compounds is developed using CTAB as the inverse phase transfer catalyst in water. The methodology developed is elaborated into the one-pot synthesis of quinoline derivatives and also applicable to the regioselective N-aralkyl of 2-pyridones.
Direct Synthesis of N‐Alkyl‐2‐Pyridones Using 2‐Halogenated Pyridines
作者:Xia Chen、Jianyi Shi、Yuqun Lin、Yibiao Li、Shaohua Jiang、Tianxiang Chen、Zhongzhi Zhu、Aijun Ma
DOI:10.1002/ejoc.202301184
日期:2024.2.12
This study presents a method for synthesizing pyridine, quinoline, and isoquinoline ketones from 2-halogenated N-heterocycles under mild conditions. The use of H2O as both solvent and oxygen source makes the reaction environmentally friendly, with broad substrate applicability and high functional group tolerance.
This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt thereof) that degrades Proto-oncogene VAV 1 protein (VAV1). The chemical entities are useful, e.g., for treating a subject (e.g., a human subject) having an inflammatory or autoimmune disorder.